Stevens, Elise M. http://orcid.org/0000-0002-0494-4362
Frank, David
Codispoti, Maurizio
Kypriotakis, George
Cinciripini, Paul M.
Claiborne, Kimberly
Deweese, Menton M.
Engelmann, Jeffrey M.
Green, Charles E.
Karam-Hage, Maher
Minnix, Jennifer A.
Ng, Jennifer
Robinson, Jason D.
Tyndale, Rachel F.
Vidrine, Damon J.
Versace, Francesco
Funding for this research was provided by:
From the Canada Research Chairs program
National Institutes of Health; University of Texas, Houston, Cancer Center Support Grant
Article History
Received: 9 August 2018
Accepted: 5 February 2019
First Online: 1 March 2019
Competing Interests
: Drs Cinciripini and Karam-Hage have received varenicline from the manufacturer Pfizer to conduct three NIH-funded studies, and participated in two multisite Pfizer-funded studies on varenicline. Dr. Tyndale has consulted for Apotex and Quinn Emmanuel on topics unrelated to this project. All the other authors declare no conflict of interest.